Shan D, Mount D, Moore S, Haroutunian V, Meador-Woodruff JH, and McCullumsmith RE:  Abnormal Partitioning of Hexokinase 1 Suggests Disruption of a Glutamate Transport Protein Complex in Schizophrenia.  Schizophrenia Research. In press.
Mueller TM, Haroutunian V, and Meador-Woodruff JH. (2013) N-Glycosylation of GABAA Receptor Subunits is Altered in Schizophrenia. Neuropsychopharmacology. 39, 528–537.
Ren X, Rizavi HS, Khan MA, Bhaumik R, Dwivedi Y, Pandey GN. Alteration of cyclic-AMP response element binding protein in the postmortem brain of subjects with bipolar disorder and schizophrenia. J Affect Disord. 2014 Jan;152-154:326-33.

Nierenberg, A.A., Sylvia, L.G., Leon, A.C., Reilly-Harrington, N.A., Shesler, L.W., McElroy, S.L., Friedman, E.S., Thase, M.E., Shelton, R.C., Bowden, C., Tohen, M., Singh, V., Deckersbach, T., Ketter, T., Kocsis, J.H., McInnis, M.G., Schoenfeld, D., Bobo, W.V., Calabrese, J.R., Bipolar CHOICE Study Group. Bipolar CHOICE: An illustration of a comparative effectiveness trial for a complex disorder. Clinical Trials (in press).

Ninan P.T., Shelton R.C., Bao W., Guico-Pabia C.J. BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxine. Progr Neuropsychopharmacol Biol Psychiatry (in press).

Bobo W.V., Epstein R.A. Jr, Hayes R.M., Shelton R.C., Hartert T.V., Mitchel E., Horner J., Wu P. The effect of regulatory advisories on maternal antidepressant prescribing, 1995-2007: an interrupted time-series study of 228,876 pregnancies Archives of Womens Mental Health 17:17–26, 2014


Sylvia LG, Friedman ES, Kocsis JH, Bernstein EE, Brody BD, Kinrys G, Kemp DE, Shelton RC, McElroy SL, Bobo WV, Kamali M, McInnis MG, Tohen M, Bowden CL, Ketter TA, Deckersbach T, Calabrese JR, Thase ME, Reilly-Harrington NA, Singh V, Rabideau DJ, Nierenberg AA. Association of exercise with quality of life and mood symptoms in a comparative effectiveness study of bipolar disorder. Journal of Affective Disorders (in press).

Fournier J.C., DeRubeis R.J., Hollon S.D., Gallop R., Shelton R.C., Amsterdam J.D. Differential change in specific depressive symptoms during antidepressant medication or cognitive therapy. Behaviour Research and Therapy (in press).

Epstein R.A., Bobo W.V., Shelton R.C., Arbogast P.G., Morrow J.A., Cooper W.O. Increasing use of atypical antipsychotics and anticonvulsants during pregnancy. Pharmacoepidemiology and Drug Safety (in press).

Webb C.A., DeRubeis R.J., Amsterdam J.D., Shelton R.C., Hollon S.D. Mechanisms of change in cognitive therapy for depression: therapist adherence, symptom change and the mediating role of patient skills. Journal of Consulting and Clinical Psychology (in press).